Analysts predict that Quintiles Transitional Holdings Inc. (NYSE:Q) will announce sales of $2.02 billion for the current quarter, according to Zacks. Nine analysts have made estimates for Quintiles Transitional Holdings’ earnings. The lowest sales estimate is $2.00 billion and the highest is $2.03 billion. Quintiles Transitional Holdings posted sales of $1.14 billion in the same quarter last year, which would indicate a positive year-over-year growth rate of 77.2%. The firm is expected to issue its next quarterly earnings results on Wednesday, November 1st.

According to Zacks, analysts expect that Quintiles Transitional Holdings will report full-year sales of $2.02 billion for the current financial year, with estimates ranging from $8.00 billion to $8.09 billion. For the next financial year, analysts anticipate that the company will post sales of $8.52 billion per share, with estimates ranging from $8.44 billion to $8.61 billion. Zacks’ sales averages are an average based on a survey of research firms that cover Quintiles Transitional Holdings.

Quintiles Transitional Holdings (NYSE:Q) last posted its earnings results on Thursday, August 3rd. The medical research company reported $1.09 earnings per share for the quarter, topping the consensus estimate of $1.05 by $0.04. The firm had revenue of $1.97 billion during the quarter, compared to analysts’ expectations of $1.96 billion. Quintiles Transitional Holdings had a return on equity of 14.23% and a net margin of 0.82%. The firm’s revenue was up 68.7% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.93 earnings per share.

A number of brokerages have weighed in on Q. BidaskClub lowered Quintiles Transitional Holdings from a “strong-buy” rating to a “buy” rating in a research note on Friday, August 11th. Jefferies Group LLC restated a “hold” rating and set a $94.00 price objective on shares of Quintiles Transitional Holdings in a research note on Friday, August 4th. William Blair upgraded Quintiles Transitional Holdings from a “market perform” rating to an “outperform” rating and raised their price objective for the company from $70.10 to $93.42 in a research note on Friday, August 4th. Citigroup Inc. raised their price objective on Quintiles Transitional Holdings from $96.00 to $97.00 and gave the company a “neutral” rating in a research note on Monday, August 7th. Finally, Stifel Nicolaus restated a “hold” rating and set a $92.00 price objective (up previously from $87.00) on shares of Quintiles Transitional Holdings in a research note on Friday, August 4th. Eleven investment analysts have rated the stock with a hold rating, eight have issued a buy rating and one has issued a strong buy rating to the company. The company presently has a consensus rating of “Buy” and a consensus target price of $90.25.

In other Quintiles Transitional Holdings news, insider Ari Bousbib sold 92,160 shares of Quintiles Transitional Holdings stock in a transaction on Monday, August 7th. The stock was sold at an average price of $90.35, for a total transaction of $8,326,656.00. Following the sale, the insider now owns 1,082,919 shares of the company’s stock, valued at approximately $97,841,731.65. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Dennis B. Ph D. Gillings sold 968,023 shares of Quintiles Transitional Holdings stock in a transaction on Monday, August 28th. The shares were sold at an average price of $97.33, for a total value of $94,217,678.59. Following the sale, the director now directly owns 9,071,839 shares in the company, valued at approximately $882,962,089.87. The disclosure for this sale can be found here. Insiders have sold a total of 6,363,847 shares of company stock worth $618,573,696 in the last ninety days. 6.40% of the stock is owned by company insiders.

Institutional investors have recently made changes to their positions in the business. Fiduciary Trust Co. bought a new stake in Quintiles Transitional Holdings during the 2nd quarter valued at $105,000. Global X Management Co. LLC raised its stake in Quintiles Transitional Holdings by 30.8% during the 1st quarter. Global X Management Co. LLC now owns 1,469 shares of the medical research company’s stock valued at $118,000 after acquiring an additional 346 shares in the last quarter. GWM Advisors LLC bought a new stake in Quintiles Transitional Holdings during the 2nd quarter valued at $122,000. Korea Investment CORP raised its stake in Quintiles Transitional Holdings by 142.5% during the 2nd quarter. Korea Investment CORP now owns 1,370 shares of the medical research company’s stock valued at $123,000 after acquiring an additional 805 shares in the last quarter. Finally, Archford Capital Strategies LLC bought a new stake in Quintiles Transitional Holdings during the 1st quarter valued at $160,000. 91.36% of the stock is currently owned by hedge funds and other institutional investors.

COPYRIGHT VIOLATION NOTICE: “Brokerages Expect Quintiles Transitional Holdings Inc. (Q) Will Post Quarterly Sales of $2.02 Billion” was reported by American Banking News and is the property of of American Banking News. If you are reading this story on another site, it was illegally copied and reposted in violation of US and international copyright & trademark laws. The correct version of this story can be accessed at https://www.americanbankingnews.com/2017/09/16/brokerages-expect-quintiles-transitional-holdings-inc-q-will-post-quarterly-sales-of-2-02-billion.html.

Shares of Quintiles Transitional Holdings (NYSE:Q) opened at 94.47 on Friday. The company’s 50-day moving average price is $93.55 and its 200 day moving average price is $86.47. The stock has a market cap of $20.46 billion, a PE ratio of 273.83 and a beta of 0.63. Quintiles Transitional Holdings has a 1-year low of $70.10 and a 1-year high of $99.95.

Quintiles Transitional Holdings announced that its Board of Directors has authorized a stock repurchase plan on Wednesday, May 24th that allows the company to buyback $1.00 billion in outstanding shares. This buyback authorization allows the medical research company to buy up to 5.4% of its shares through open market purchases. Shares buyback plans are generally a sign that the company’s board of directors believes its shares are undervalued.

About Quintiles Transitional Holdings

Quintiles IMS Holdings, Inc, formerly Quintiles Transnational Holdings Inc, provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services.

Get a free copy of the Zacks research report on Quintiles Transitional Holdings (Q)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Quintiles Transitional Holdings (NYSE:Q)

Receive News & Ratings for Quintiles Transitional Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quintiles Transitional Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.